Purinostat
Small moleculeexperimental
Clinical trial activity
6 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
5
Phase 3
1
Phase 4
0
Earliest trial started Aug 19, 2020 (NCT05526313)
Timeline
Indications
Mechanism of action
- Histone deacetylase 1ANTAGONIST
HDAC1 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07011056 | Phase 3 | Jul 18, 2025 | Government of China |
| NCT06484829 | Phase 1/Phase 2 (Phase 2) | Jun 26, 2024 | Government of China, Sichuan University |
| NCT06431243 | Phase 1/Phase 2 (Phase 2) | May 31, 2024 | Government of China, Sichuan University, Sun Yat-Sen University |
| NCT06485219 | Phase 2 | Nov 22, 2023 | Government of China, Jiao Tong University, Sichuan University |
| NCT05563844 | Phase 2 | Dec 1, 2022 | Government of China, Jiao Tong University, Sichuan University |
| NCT05526313 | Phase 1 | Aug 19, 2020 | Government of China, Sichuan University |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 6 | 6 | 3 | 2020 |
| Sichuan University | Academic/Hospital | 5 | 0 | 2 | 2020 |
| Jiao Tong University | Academic/Hospital | 2 | 0 | 1 | 2022 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2024 |
4 organizations
Page 1 / 1